Our key question was to determine the presence of IL-18Rα on immune cell populations in the mouse model of mild and severe disease, and whether IL-18Rα levels mirrored our data obtained from A/H7N9, COVID-19, RSV and MIS-C patient cohorts. This evidence concerns the gene IL18R1 and COVID-19.